Page last updated: 2024-10-30

maprotiline and Malignant Melanoma

maprotiline has been researched along with Malignant Melanoma in 1 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Research Excerpts

ExcerptRelevanceReference
"This study aimed to investigate the antitumour efficacy of maprotiline in mice with melanoma."8.84Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma. ( Chen, H; Guo, J; Jia, H; Jiang, H; Jiao, Y; Li, Y; Liang, L; Shao, M; Wu, Z; Zhang, C; Zhao, T, 2024)
"This study aimed to investigate the antitumour efficacy of maprotiline in mice with melanoma."4.84Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma. ( Chen, H; Guo, J; Jia, H; Jiang, H; Jiao, Y; Li, Y; Liang, L; Shao, M; Wu, Z; Zhang, C; Zhao, T, 2024)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liang, L1
Li, Y1
Jiao, Y1
Zhang, C1
Shao, M1
Jiang, H1
Wu, Z1
Chen, H1
Guo, J1
Jia, H1
Zhao, T1

Other Studies

1 other study available for maprotiline and Malignant Melanoma

ArticleYear
Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma.
    Current molecular pharmacology, 2024, Volume: 17, Issue:1

    Topics: Animals; B7-H1 Antigen; Female; Maprotiline; Melanoma; Mice; Mice, Inbred C57BL; Programmed Cell Dea

2024